JP2025509134A5 - - Google Patents

Info

Publication number
JP2025509134A5
JP2025509134A5 JP2024551528A JP2024551528A JP2025509134A5 JP 2025509134 A5 JP2025509134 A5 JP 2025509134A5 JP 2024551528 A JP2024551528 A JP 2024551528A JP 2024551528 A JP2024551528 A JP 2024551528A JP 2025509134 A5 JP2025509134 A5 JP 2025509134A5
Authority
JP
Japan
Prior art keywords
alkyl
heterocycloalkyl
cycloalkyl
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024551528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025509134A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/015518 external-priority patent/WO2023177877A1/en
Publication of JP2025509134A publication Critical patent/JP2025509134A/ja
Publication of JP2025509134A5 publication Critical patent/JP2025509134A5/ja
Pending legal-status Critical Current

Links

JP2024551528A 2022-03-17 2023-03-17 ラリネパグプロドラッグおよびその使用 Pending JP2025509134A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263321032P 2022-03-17 2022-03-17
US63/321,032 2022-03-17
PCT/US2023/015518 WO2023177877A1 (en) 2022-03-17 2023-03-17 Ralinepag prodrugs and uses thereof

Publications (2)

Publication Number Publication Date
JP2025509134A JP2025509134A (ja) 2025-04-11
JP2025509134A5 true JP2025509134A5 (https=) 2026-03-25

Family

ID=88024192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024551528A Pending JP2025509134A (ja) 2022-03-17 2023-03-17 ラリネパグプロドラッグおよびその使用

Country Status (9)

Country Link
US (2) US20240002334A1 (https=)
EP (1) EP4493540A4 (https=)
JP (1) JP2025509134A (https=)
KR (1) KR20240165382A (https=)
CN (1) CN119110796A (https=)
AU (1) AU2023236147A1 (https=)
CA (1) CA3245146A1 (https=)
IL (1) IL315472A (https=)
WO (1) WO2023177877A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023158634A1 (en) 2022-02-15 2023-08-24 United Therapeutics Corporation Crystalline prostacyclin (ip) receptor agonist and uses thereof
US20240139207A1 (en) 2022-10-31 2024-05-02 United Therapeutics Corporation Methods for treating pulmonary hypertension
US20250282716A1 (en) 2024-03-11 2025-09-11 United Therapeutics Corporation Methods of making ip-receptor agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009117095A1 (en) * 2008-03-18 2009-09-24 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto

Similar Documents

Publication Publication Date Title
JP2025509134A5 (https=)
JP2024520481A5 (https=)
JP2024514837A5 (https=)
JP2022505987A5 (https=)
JP2025505994A5 (https=)
JP2008510691A5 (https=)
RU2009115653A (ru) Производные 5-замещенного хиназолинона, содержащие их композиции и способы их применения
JP2022510313A5 (https=)
JP2024522174A5 (https=)
JP2005523922A5 (https=)
JP2020169171A5 (https=)
JP2006505543A5 (https=)
JP2005504749A5 (https=)
JP2021514001A5 (https=)
JP2008516945A5 (https=)
JP2023504542A5 (https=)
JP2008510828A5 (https=)
JP2022533069A5 (https=)
JP2009529540A5 (https=)
JP2008503515A5 (https=)
JP2009536221A5 (https=)
JP2025502943A5 (https=)
JP2020128426A5 (https=)
JP2025507292A5 (https=)
JP2021528488A5 (https=)